# TNK-tPA Evaluation for Minor Ischemic Stroke With Proven Occlusion

> **NCT01654445** · PHASE2 · COMPLETED · sponsor: **University of Calgary** · enrollment: 50 (actual)

## Conditions studied

- Ischemic Stroke

## Interventions

- **DRUG:** Tenecteplase

## Key facts

- **NCT ID:** NCT01654445
- **Lead sponsor:** University of Calgary
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-07
- **Primary completion:** 2014-07
- **Final completion:** 2014-07
- **Target enrollment:** 50 (ACTUAL)
- **Last updated:** 2020-11-25

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01654445

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01654445, "TNK-tPA Evaluation for Minor Ischemic Stroke With Proven Occlusion". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT01654445. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*